NO982588L - Procedure for the diagnosis and treatment of squamous cell carcinoma - Google Patents

Procedure for the diagnosis and treatment of squamous cell carcinoma

Info

Publication number
NO982588L
NO982588L NO982588A NO982588A NO982588L NO 982588 L NO982588 L NO 982588L NO 982588 A NO982588 A NO 982588A NO 982588 A NO982588 A NO 982588A NO 982588 L NO982588 L NO 982588L
Authority
NO
Norway
Prior art keywords
diagnosis
procedure
treatment
cell carcinoma
squamous cell
Prior art date
Application number
NO982588A
Other languages
Norwegian (no)
Other versions
NO319903B1 (en
NO982588D0 (en
Inventor
Karl-Heinz Heider
G Nter Adolf
Elinborg Ostermann
Erik Patzelt
Marlies Sproll
Original Assignee
Boehringer Ingelheim Int
Karlsruhe Forschzent
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19545472A external-priority patent/DE19545472A1/en
Application filed by Boehringer Ingelheim Int, Karlsruhe Forschzent filed Critical Boehringer Ingelheim Int
Publication of NO982588D0 publication Critical patent/NO982588D0/en
Publication of NO982588L publication Critical patent/NO982588L/en
Publication of NO319903B1 publication Critical patent/NO319903B1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1027—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against receptors, cell-surface antigens or cell-surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70585—CD44
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2884—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD44
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Optics & Photonics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO19982588A 1995-12-06 1998-06-05 Use of an antibody molecule for the preparation of a pharmaceutical composition for the treatment of squamous cell carcinoma. NO319903B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19545472A DE19545472A1 (en) 1995-12-06 1995-12-06 Diagnosis of squamous epithelial cell carcinoma
DE19615074 1996-04-17
PCT/EP1996/005448 WO1997021104A1 (en) 1995-12-06 1996-12-05 Method of diagnosing and treating epithelioma

Publications (3)

Publication Number Publication Date
NO982588D0 NO982588D0 (en) 1998-06-05
NO982588L true NO982588L (en) 1998-08-05
NO319903B1 NO319903B1 (en) 2005-09-26

Family

ID=26020988

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19982588A NO319903B1 (en) 1995-12-06 1998-06-05 Use of an antibody molecule for the preparation of a pharmaceutical composition for the treatment of squamous cell carcinoma.

Country Status (26)

Country Link
EP (1) EP0865609B1 (en)
JP (1) JP2000502067A (en)
KR (1) KR100473824B1 (en)
CN (1) CN1151377C (en)
AR (1) AR004360A1 (en)
AT (1) ATE235056T1 (en)
AU (1) AU726704B2 (en)
BG (1) BG62985B1 (en)
BR (1) BR9611901A (en)
CA (1) CA2239709A1 (en)
CO (1) CO4520233A1 (en)
CZ (1) CZ174198A3 (en)
DE (1) DE59610248D1 (en)
DK (1) DK0865609T3 (en)
EE (1) EE03783B1 (en)
ES (1) ES2190484T3 (en)
HK (1) HK1011560A1 (en)
MX (1) MX9804459A (en)
NO (1) NO319903B1 (en)
NZ (1) NZ324314A (en)
PL (1) PL184521B1 (en)
PT (1) PT865609E (en)
SK (1) SK284378B6 (en)
TR (1) TR199801027T2 (en)
UY (1) UY24389A1 (en)
WO (1) WO1997021104A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7189397B2 (en) * 1999-10-08 2007-03-13 Arius Research Inc. Cytotoxicity mediation of cells evidencing surface expression of CD44
US20050100542A1 (en) * 1999-10-08 2005-05-12 Young David S. Cytotoxicity mediation of cells evidencing surface expression of CD44
PE20021098A1 (en) * 2001-05-18 2003-02-11 Boehringer Ingelheim Int CD44v6 SPECIFIC ANTIBODIES
US20030103985A1 (en) 2001-05-18 2003-06-05 Boehringer Ingelheim International Gmbh Cytotoxic CD44 antibody immunoconjugates
US6972324B2 (en) 2001-05-18 2005-12-06 Boehringer Ingelheim Pharmaceuticals, Inc. Antibodies specific for CD44v6
EP1258255A1 (en) * 2001-05-18 2002-11-20 Boehringer Ingelheim International GmbH Conjugates of an antibody to CD44 and a maytansinoid
EP1391213A1 (en) * 2002-08-21 2004-02-25 Boehringer Ingelheim International GmbH Compositions and methods for treating cancer using maytansinoid CD44 antibody immunoconjugates and chemotherapeutic agents
EP1417974A1 (en) * 2002-11-08 2004-05-12 Boehringer Ingelheim International GmbH Compositions and methods for treating cancer using cytotoxic CD44 antibody immunoconjugates and radiotherapy
CN102741292B (en) * 2010-02-04 2015-10-21 霍夫曼-拉罗奇有限公司 The CD44 monoclonal antibody used in treatment head and neck squamous cell carcinoma
US9218450B2 (en) 2012-11-29 2015-12-22 Roche Molecular Systems, Inc. Accurate and fast mapping of reads to genome
WO2019161528A1 (en) * 2018-02-22 2019-08-29 Abmart Shanghai Co., Ltd. Therapeutic antibody and uses thereof
WO2023227644A2 (en) 2022-05-25 2023-11-30 Akiram Therapeutics Ab Binding protein

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08511419A (en) * 1993-06-18 1996-12-03 ヤルカネン、シルパ Composition and diagnostic method using monoclonal antibody against CD44v6
EP0767378A1 (en) * 1993-06-22 1997-04-09 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Method for the diagnosis and analysis of stomach carcinoma
DE4326573A1 (en) * 1993-08-07 1995-02-23 Boehringer Ingelheim Int Polypeptides encoded by exon v5 of the CD44 gene as targets for immunotherapy and immunoscintigraphy of tumors
UA58482C2 (en) * 1994-06-08 2003-08-15 Бьорінгер Інгельхайм Інтернаціональ Гмбх MONOCLONAL ANTIBODY VFF-18 AGAINST CD44v6 AND ITS FRAGMENTS

Also Published As

Publication number Publication date
ES2190484T3 (en) 2003-08-01
KR19990071952A (en) 1999-09-27
KR100473824B1 (en) 2005-09-30
WO1997021104A1 (en) 1997-06-12
JP2000502067A (en) 2000-02-22
DE59610248D1 (en) 2003-04-24
EE9800164A (en) 1998-12-15
MX9804459A (en) 1998-09-30
EE03783B1 (en) 2002-06-17
CN1151377C (en) 2004-05-26
PL184521B1 (en) 2002-11-29
CZ174198A3 (en) 1999-02-17
CN1207811A (en) 1999-02-10
AR004360A1 (en) 1998-11-04
NO319903B1 (en) 2005-09-26
BG62985B1 (en) 2000-12-29
PT865609E (en) 2003-08-29
CO4520233A1 (en) 1997-10-15
NO982588D0 (en) 1998-06-05
ATE235056T1 (en) 2003-04-15
DK0865609T3 (en) 2003-06-23
UY24389A1 (en) 2001-10-25
AU726704B2 (en) 2000-11-16
BG102513A (en) 1999-02-26
PL327066A1 (en) 1998-11-23
SK284378B6 (en) 2005-02-04
HK1011560A1 (en) 1999-07-16
SK73698A3 (en) 1999-01-11
NZ324314A (en) 2000-02-28
TR199801027T2 (en) 1998-10-21
BR9611901A (en) 1999-03-02
CA2239709A1 (en) 1997-06-12
EP0865609B1 (en) 2003-03-19
AU1177397A (en) 1997-06-27
EP0865609A1 (en) 1998-09-23

Similar Documents

Publication Publication Date Title
NO983183L (en) Mixtures and Procedures for the Treatment and Diagnosis of Breast Cancer
DE69529307D1 (en) Ultrasound diagnosis and treatment system
NO976063D0 (en) Procedure for the treatment of diabetes
NO20013002D0 (en) Mixtures and methods for the treatment and diagnosis of ovarian cancer
KR950703893A (en) DIAGNOSTIC PATCH AND METHOD FOR DIAGNOSIS USING THE SAME
NO894296L (en) PROCEDURE FOR THE TREATMENT OF ARTHY AND INFLAMMATORY DISEASES.
NO971015D0 (en) Compounds and Methods for the Treatment of Cancer
DK1091D0 (en) IMMUNCONJUGATES FOR DIAGNOSIS AND CANCER TREATMENT
DE69522448D1 (en) TISSUE TREATMENT CASSETTE
NO890793D0 (en) PROCEDURE AND INSTALLATION FOR WATER TREATMENT.
NO991693D0 (en) Compounds and methods for the diagnosis of tuberculosis
NO914344D0 (en) PROCEDURE AND DEVICE FOR WATER SHARE MONITORING
NO903948L (en) PROCEDURE AND DEVICE FOR WATER SHARE MONITORING.
FI971568A (en) Procedure for the treatment of resistant tumors
NO994932D0 (en) Mixtures and Procedures for the Treatment and Diagnosis of Breast Cancer
IL110464A0 (en) Novel proteins for the diagnosis, imaging, and therapy of human cancer
NO982588L (en) Procedure for the diagnosis and treatment of squamous cell carcinoma
NO872064D0 (en) PROCEDURE AND DEVICE FOR PERFORING THE BROWN.
NO983512D0 (en) Means for the treatment and prevention of AIDS
NO850642L (en) PROCEDURE AND DEVICE FOR WATER TREATMENT.
NO895131D0 (en) PROCEDURE FOR ANALYSIS OF BLOOD PLATE CONNECTIONS AND DEVICE FOR CARRYING OUT THE PROCEDURE.
DE68905298D1 (en) GASKET AND MEDICAL DEVICE USING THIS.
NZ306122A (en) Rage tumour rejection antigen precursors, diagnosis and treatment thereby
IT1281294B1 (en) JEWEL AND PROCEDURE FOR THE REALIZATION OF THE SAME.
NO905543L (en) PROCEDURE FOR THE PREPARATION AND USE OF AMINOPYRIDINYLMETHANOLS AND AMINOMETHYLPYRIDINAMINES.